Clinical	0	8	O
significance	9	21	O
of	22	24	O
chicken	25	32	B-Gene_or_gene_product
ovalbumin	33	42	I-Gene_or_gene_product
upstream	43	51	I-Gene_or_gene_product
promoter	52	60	I-Gene_or_gene_product
-	60	61	I-Gene_or_gene_product
transcription	61	74	I-Gene_or_gene_product
factor	75	81	I-Gene_or_gene_product
II	82	84	I-Gene_or_gene_product
expression	85	95	O
in	96	98	O
human	99	104	B-Organism
colorectal	105	115	B-Pathological_formation
cancer	116	122	I-Pathological_formation
.	122	123	O

Chicken	125	132	B-Gene_or_gene_product
ovalbumin	133	142	I-Gene_or_gene_product
upstream	143	151	I-Gene_or_gene_product
promoter	152	160	I-Gene_or_gene_product
-	160	161	I-Gene_or_gene_product
transcription	161	174	I-Gene_or_gene_product
factor	175	181	I-Gene_or_gene_product
II	182	184	I-Gene_or_gene_product
(	185	186	O
COUP	186	190	B-Gene_or_gene_product
-	190	191	I-Gene_or_gene_product
TFII	191	195	I-Gene_or_gene_product
)	195	196	O
plays	197	202	O
an	203	205	O
essential	206	215	O
role	216	220	O
in	221	223	O
angiogenesis	224	236	O
and	237	240	O
development	241	252	O
.	252	253	O

A	254	255	O
previous	256	264	O
study	265	270	O
showed	271	277	O
that	278	282	O
the	283	286	O
expression	287	297	O
of	298	300	O
COUP	301	305	B-Gene_or_gene_product
-	305	306	I-Gene_or_gene_product
TFII	306	310	I-Gene_or_gene_product
enhanced	311	319	O
invasiveness	320	332	O
of	333	335	O
human	336	341	B-Organism
lung	342	346	B-Cell
carcinoma	347	356	I-Cell
cells	357	362	I-Cell
.	362	363	O

However	364	371	O
,	371	372	O
no	373	375	O
published	376	385	O
data	386	390	O
are	391	394	O
available	395	404	O
concerning	405	415	O
the	416	419	O
biological	420	430	O
and	431	434	O
clinical	435	443	O
significance	444	456	O
of	457	459	O
COUP	460	464	B-Gene_or_gene_product
-	464	465	I-Gene_or_gene_product
TFII	465	469	I-Gene_or_gene_product
expression	470	480	O
in	481	483	O
colorectal	484	494	B-Pathological_formation
cancer	495	501	I-Pathological_formation
.	501	502	O

Thus	503	507	O
,	507	508	O
our	509	512	O
objective	513	522	O
was	523	526	O
to	527	529	O
explore	530	537	O
the	538	541	O
expression	542	552	O
of	553	555	O
COUP	556	560	B-Gene_or_gene_product
-	560	561	I-Gene_or_gene_product
TFII	561	565	I-Gene_or_gene_product
in	566	568	O
colorectal	569	579	B-Pathological_formation
cancer	580	586	I-Pathological_formation
as	587	589	O
well	590	594	O
as	595	597	O
its	598	601	O
association	602	613	O
with	614	618	O
clinicopathological	619	638	O
features	639	647	O
,	647	648	O
and	649	652	O
to	653	655	O
evaluate	656	664	O
the	665	668	O
role	669	673	O
of	674	676	O
COUP	677	681	B-Gene_or_gene_product
-	681	682	I-Gene_or_gene_product
TFII	682	686	I-Gene_or_gene_product
as	687	689	O
a	690	691	O
prognostic	692	702	O
indicator	703	712	O
in	713	715	O
colorectal	716	726	B-Pathological_formation
cancer	727	733	I-Pathological_formation
.	733	734	O

We	735	737	O
investigated	738	750	O
the	751	754	O
presence	755	763	O
of	764	766	O
COUP	767	771	B-Gene_or_gene_product
-	771	772	I-Gene_or_gene_product
TFII	772	776	I-Gene_or_gene_product
in	777	779	O
human	780	785	B-Organism
colorectal	786	796	B-Tissue
cancer	797	803	I-Tissue
tissues	804	811	I-Tissue
and	812	815	O
adjacent	816	824	O
normal	825	831	B-Tissue
tissues	832	839	I-Tissue
from	840	844	O
95	845	847	O
primary	848	855	O
colorectal	856	866	B-Pathological_formation
cancer	867	873	I-Pathological_formation
patients	874	882	B-Organism
by	883	885	O
immunohistochemistry	886	906	O
.	906	907	O

The	908	911	O
correlation	912	923	O
between	924	931	O
the	932	935	O
expression	936	946	O
of	947	949	O
COUP	950	954	B-Gene_or_gene_product
-	954	955	I-Gene_or_gene_product
TFII	955	959	I-Gene_or_gene_product
and	960	963	O
clinicopathologic	964	981	O
features	982	990	O
was	991	994	O
investigated	995	1007	O
.	1007	1008	O

The	1009	1012	O
3	1013	1014	O
-	1014	1015	O
year	1015	1019	O
disease	1020	1027	O
-	1027	1028	O
free	1028	1032	O
survival	1033	1041	O
(	1042	1043	O
DFS	1043	1046	O
)	1046	1047	O
and	1048	1051	O
overall	1052	1059	O
survival	1060	1068	O
(	1069	1070	O
OS	1070	1072	O
)	1072	1073	O
of	1074	1076	O
patients	1077	1085	B-Organism
with	1086	1090	O
tumors	1091	1097	B-Pathological_formation
expressing	1098	1108	O
different	1109	1118	O
levels	1119	1125	O
of	1126	1128	O
COUP	1129	1133	B-Gene_or_gene_product
-	1133	1134	I-Gene_or_gene_product
TFII	1134	1138	I-Gene_or_gene_product
were	1139	1143	O
evaluated	1144	1153	O
by	1154	1156	O
the	1157	1160	O
Kaplan	1161	1167	O
-	1167	1168	O
Meier	1168	1173	O
method	1174	1180	O
.	1180	1181	O

No	1182	1184	O
significant	1185	1196	O
correlation	1197	1208	O
was	1209	1212	O
found	1213	1218	O
between	1219	1226	O
COUP	1227	1231	B-Gene_or_gene_product
-	1231	1232	I-Gene_or_gene_product
TFII	1232	1236	I-Gene_or_gene_product
expression	1237	1247	O
and	1248	1251	O
age	1252	1255	O
at	1256	1258	O
surgery	1259	1266	O
,	1266	1267	O
gender	1268	1274	O
,	1274	1275	O
histopathologic	1276	1291	O
differentiation	1292	1307	O
,	1307	1308	O
vessel	1309	1315	B-Multi-tissue_structure
invasion	1316	1324	O
,	1324	1325	O
carcinoembryonic	1326	1342	B-Gene_or_gene_product
antigen	1343	1350	I-Gene_or_gene_product
(	1351	1352	O
CEA	1352	1355	B-Gene_or_gene_product
)	1355	1356	O
,	1356	1357	O
or	1358	1360	O
nodal	1361	1366	O
involvement	1367	1378	O
.	1378	1379	O

However	1380	1387	O
,	1387	1388	O
survival	1389	1397	O
analysis	1398	1406	O
showed	1407	1413	O
that	1414	1418	O
the	1419	1422	O
COUP	1423	1427	B-Gene_or_gene_product
-	1427	1428	I-Gene_or_gene_product
TFII	1428	1432	I-Gene_or_gene_product
-	1432	1433	O
positive	1433	1441	O
group	1442	1447	O
had	1448	1451	O
a	1452	1453	O
significantly	1454	1467	O
better	1468	1474	O
OS	1475	1477	O
compared	1478	1486	O
to	1487	1489	O
COUP	1490	1494	B-Gene_or_gene_product
-	1494	1495	I-Gene_or_gene_product
TFII	1495	1499	I-Gene_or_gene_product
-	1499	1500	O
negative	1500	1508	O
group	1509	1514	O
(	1515	1516	O
80	1516	1518	O
.	1518	1519	O
4	1519	1520	O
%	1520	1521	O
vs	1522	1524	O
.	1524	1525	O
57	1526	1528	O
.	1528	1529	O
7	1529	1530	O
%	1530	1531	O
,	1531	1532	O
P	1533	1534	O
=	1534	1535	O
0	1535	1536	O
.	1536	1537	O
0491	1537	1541	O
)	1541	1542	O
.	1542	1543	O

Based	1544	1549	O
on	1550	1552	O
our	1553	1556	O
results	1557	1564	O
,	1564	1565	O
COUP	1566	1570	B-Gene_or_gene_product
-	1570	1571	I-Gene_or_gene_product
TFII	1571	1575	I-Gene_or_gene_product
may	1576	1579	O
represent	1580	1589	O
a	1590	1591	O
biomarker	1592	1601	O
for	1602	1605	O
good	1606	1610	O
prognosis	1611	1620	O
in	1621	1623	O
colorectal	1624	1634	B-Pathological_formation
cancer	1635	1641	I-Pathological_formation
.	1641	1642	O

